AL

Alma Yesodot Ltd.

KVSR | TA

Overview

Corporate Details

ISIN(s):
IL0011731457
LEI:
Country:
Israel
Address:
HaBarzel 3, 6971005 Tel Aviv - Jaffa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kvasir focuses on developing innovative medical devices and diagnostic technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Alma Yesodot Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-24 17:08
Regulatory News Service
Opening of Trading on April 27 2025-ALMA YESODOT B1
Hebrew (modern) 118.8 KB
2025-04-23 11:59
Regulatory News Service
Identifying Details of New Security-ALMA YESODOT B1
Hebrew (modern) 87.5 KB
2024-11-05 15:46
Regulatory News Service
Changes in the company's name and security, effective as of November 7, 2024
Hebrew (modern) 108.5 KB
2024-10-29 18:37
Regulatory News Service
The sector classification of the company will be changed, as of October 31, 202…
Hebrew (modern) 121.3 KB
2024-10-29 17:20
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2023-05-22 23:20
Report Publication Announcement
Frost and Sullivan is terminating coverage , following the completion of its co…
Hebrew (modern) 174.5 KB
2023-05-22 23:20
Pre-Annual General Meeting Information
Frost and Sullivan is terminating coverage , following the completion of its co…
Russian 46.0 KB
2023-03-23 21:00
Investor Presentation
Analysis update following financial report- price target is updated to NIS 22.7
English 1.2 MB
2023-03-23 21:00
Legal Proceedings Report
Analysis update following financial report- price target is updated to NIS 22.7
Russian 71.0 KB
2022-12-11 20:40
Investor Presentation
Analysis update following financial report- price target is updated to NIS 32.9…
English 1.2 MB
2022-12-11 20:40
Business and Financial Review
Analysis update following financial report- price target is updated to NIS 32.9…
Russian 67.3 KB
2022-08-30 20:47
Investor Presentation
Analysis update report ,target price is at 47.6NIS
English 1.2 MB
2022-08-30 20:47
Business and Financial Review
Analysis update report ,target price is at 47.6NIS
Russian 63.9 KB
2022-08-18 16:58
Investor Presentation
Presentation
English 3.0 MB
2022-08-18 16:58
Pre-Annual General Meeting Information
Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Alma Yesodot Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alma Yesodot Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
CellSeed Inc. Logo
Develops cell sheet products, culture equipment, and offers contract manufacturing services.
Japan 7776
CellSource Co.,Ltd. Logo
Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.
Japan 4880
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland CLN
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark CESSA
Chemical Works of Gedeon Richter Plc Logo
Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.
Hungary RICHT

Talk to a Data Expert

Have a question? We'll get back to you promptly.